Sharp Weekly Decline Brings BTSG Near Attractive Entry, Risks Remain Elevated
Read source articleWhat happened
BrightSpring Health Services shares plunged 18.1% in a week, undoing months of momentum as the market abruptly repriced the stock’s premium valuation against mounting policy and share-supply worries. The selloff, triggered by fresh concerns over IRA-driven pharmacy headwinds and integration costs, brings the stock to around $55—right at the attractive entry level we previously identified. Our deep-dive work had already flagged that Pharmacy Solutions’ script volumes were declining even as mix and pricing lifted revenue, a fragile setup that the market is now recognizing. Meanwhile, the sponsor overhang persists with KKR still holding ~13.7% and a lock-up expiry looming in early August 2026, creating a technical ceiling. The drop validates our WAIT call and underscores the need for hard evidence that the growth narrative can survive without structurally higher costs and equity dilution.
Implication
While the steep decline brings valuation into a more favorable zone, investors should defer buying until Q2’26 results demonstrate that Pharmacy Solutions prescription volumes are stabilizing and that SG&A growth is decelerating. Lingering IRA pressures and a potential KKR follow-on after the August lock-up expiration could easily drive shares lower, making patience critical. If the company can sustain its raised FY2026 EBITDA guidance midpoint without relying on transient mix benefits, a re-rating toward our $68 base case becomes plausible. Until then, a WAIT stance is prudent; re-entry should be conditional on visible operating leverage and a clear reduction in equity supply threats.
Thesis delta
The 18.1% weekly crash reinforces our existing cautious thesis and moves the stock closer to our attractive entry, but it does not change the fundamental story. The market is now reacting to the very risks we highlighted: rich valuation, IRA policy drag, and persistent sponsor selling, all of which keep us in a WAIT posture until operational clarity emerges.
Confidence
high